Skip to main content
Premium Trial:

Request an Annual Quote

OGT Licenses Array IP to Two More Japanese Companies

NEW YORK (GenomeWeb News) – Two more Japanese companies have licensed Oxford Gene Technology’s oligonucleotide microarray patents to sell arrays, OGT said today.
 
Bio Matrix Research, a bio venture company launched by Tokyo University of Science, will develop and commercialize products and microarrays to be marketed in Japan, the company said.
 
Filgen will conduct a microarray service in Japan using licensed microarrays.
 
The licenses will remain valid for the patents’ lifetime.
 
Financial details were not disclosed.
 
OGT this month has licensed its patents to Japanese companies Yamatake and NGK Insulators.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.